Mergers & Acquisitions

  • March 26, 2026

    Ex-Flooring CEO Loses Fee Fight In Chancery

    The Delaware Chancery Court on Thursday ruled against former flooring executive Brian Carson in his bid to force his former company to cover his legal fees, finding he was not entitled to advancement under the governing LLC agreement.

  • March 26, 2026

    Musk's SpaceX Eyes $75B IPO Raise, Among Other Rumors

    The market is anticipating what could be one of the largest initial public offerings ever, after reports this past week indicated that Elon Musk's SpaceX is looking to imminently raise as much as $75 billion.

  • March 26, 2026

    Creditors, US Trustee Protest Jones Day In Vanderbilt Case

    The U.S. Trustee's Office and a group of creditors have urged a New York bankruptcy judge to reject mining company Vanderbilt Minerals' bid to retain Jones Day as counsel, arguing the law firm is conflicted because it represented the debtor's parent company prior to Vanderbilt's Chapter 11 case.

  • March 26, 2026

    FCC Defends Waiver Power In Nexstar-Tegna Merger Fight

    The Federal Communications Commission on Thursday defended its authority to waive the television station ownership cap and approve the transfers at the heart of Nexstar's $6.2 billion acquisition of Tegna, telling the D.C. Circuit that the cap, as an agency rule, can be dispensed with for good cause.

  • March 26, 2026

    Shield AI Hits $12.7B Valuation, Buys Defense Biz Aechelon

    Defense technology company Shield AI on Thursday revealed that its valuation soared to $12.7 billion after closing a $1.5 billion Series G funding round, which will help finance the company's planned acquisition of private equity-backed defense company Aechelon Technology Inc.

  • March 26, 2026

    Paul Weiss, Skadden Guide $22B US Life Insurance Merger

    Corebridge Financial Inc. and Equitable Holdings Inc. said Thursday they have agreed to merge in an all-stock transaction that values the combined company at about $22 billion, in a deal steered by Skadden Arps Slate Meagher & Flom LLP and Paul Weiss Rifkind Wharton & Garrison LLP.

  • March 26, 2026

    France's Vinci To Buy 9 Toll Highways In India For $1.6B

    French construction group Vinci said Thursday that it will buy nine toll highways in India from Macquarie Group for approximately 150 billion Indian rupees ($1.6 billion) to boost its investments in mobility infrastructure.

  • March 26, 2026

    Germany's Henkel To Buy Hair Care Brand Olaplex For $1.4B

    Chemicals group Henkel said Thursday that it will buy hair care brand Olaplex in a $1.4 billion cash deal that will allow U.S. private equity firm Advent to fully exit its position.

  • March 25, 2026

    Split Del. High Court Affirms Paramount Merger Docs Ruling

    In a split decision, the Delaware Supreme Court on Wednesday agreed with a lower court's finding that news articles containing anonymous sourcing were reliable enough to support investors' demands for records pertaining to Paramount Global's merger with Skydance Media.

  • March 25, 2026

    Oak View Exec Tells Jury Of Deal To Hype Ticketmaster

    The CEO of Oak View Group told a Manhattan federal jury Wednesday that his company didn't inform other venue owners that it was being paid to "advocate" for them to use Ticketmaster as a vendor for ticketing services, but said he still would recommend the Live Nation subsidiary anyway since it's the best in the business.

  • March 25, 2026

    Nexstar Says No Harm On The Horizon From $6.2B Tegna Deal

    Nexstar and Tegna have come out swinging against a "last-minute, unfounded" attempt by eight states to block the companies from continuing to co-mingle their businesses following their $6.2 billion television station merger after receiving the go-ahead from the Federal Communications Commission.

  • March 25, 2026

    Tax-Credit Cliff Sparks M&A Rush For Clean Energy

    The looming July cutoff to maintain eligibility for clean electricity investment and production tax credits is sparking a dealmaking spree as smaller developers who are unable to meet the deadline begin looking to sell projects to deeper-pocketed players who can.

  • March 25, 2026

    S. Korea, Elliott Dispute Over Samsung Merger Set To Restart

    South Korea's Ministry of Justice said Wednesday it is preparing for U.S. hedge fund Elliott Associates to resubmit its claim accusing the government of interfering in an $8 billion merger between two Samsung affiliates in 2015, weeks after a London court set aside a previous award in the dispute.

  • March 25, 2026

    Conn. Regulators Approve $2.4B Eversource Water Co. Sale

    Connecticut's Public Utilities Regulatory Authority on Wednesday approved the transfer of Eversource subsidiary Aquarion Co. to a new public water authority created by the state Legislature, subject to several conditions, while admitting the $2.35 billion price tag placed the deal "on the knife's edge of a public interest finding."

  • March 25, 2026

    Colo. AG Says States Must Guard Rule Of Law In Antitrust

    Colorado Attorney General Philip J. Weiser said on Wednesday that state enforcers need to uphold the rule of law when it comes to antitrust enforcement because the U.S. Department of Justice is allowing lobbyists to influence outcomes.

  • March 25, 2026

    Arxis Files IPO As More Defense Firms Seek Public Listings

    Military electronics and components maker Arxis has filed plans for an initial public offering, marking the second military technology company to launch plans for a public debut this week as more aerospace and military companies seek the public markets.

  • March 25, 2026

    After Overhaul Nixed, FTC, DOJ Mull New Merger Rulemaking

    The Federal Trade Commission and the U.S. Department of Justice are not giving up on attempting to overhaul the "insufficient" half-century-old merger notification form after its replacement was just struck down by a Texas federal judge, with the agencies now seeking public comment as they mull "a new rulemaking process."

  • March 25, 2026

    Insurer Need Not Cover Parkinson's Drug Antitrust Dispute

    An insurer does not owe coverage in an antitrust suit accusing a pharmaceutical company of suppressing generic versions of the Parkinson's treatment Apokyn, a Maryland federal judge ruled, finding the dispute does not involve "securities claims" covered under the insurer's policy.

  • March 25, 2026

    3 Canadian Law Firms Steer $6.5B Boralex PE Buyout

    Brookfield Asset Management and La Caisse have agreed to acquire all of Boralex Inc.'s outstanding shares in a deal that gives the Canadian renewable power producer an enterprise value of CA$9 billion, or about $6.5 billion, according to a deal announcement Wednesday. 

  • March 25, 2026

    Covington, Freshfields Advise On $6.7B Merck Oncology Deal

    Merck & Co. said Wednesday it will acquire clinical-stage oncology company Terns Pharmaceuticals Inc. for $53 per share in cash, giving the deal an equity value of $6.7 billion.

  • March 25, 2026

    Diageo To Sell Indian Cricket Team To Blackstone For $1.8B

    Guinness owner Diageo PLC said Wednesday that it is selling Indian cricket champions Royal Challengers Bengaluru to a consortium including Blackstone for 166.6 billion Indian rupees ($1.77 billion).

  • March 24, 2026

    Charlie Javice Can't Get Retrial Based On Clerk Conflicts

    A New York federal judge Tuesday shot down a retrial bid from Charlie Javice, who was convicted of conning JPMorgan Chase & Co. into buying her financial aid startup Frank, rejecting her argument that there was a conflict of interest because clerks who worked on the trial accepted jobs with the bank's firm.

  • March 24, 2026

    Iowa Asks 5th Circ. To Ax 'Uncertain' Schwab Antitrust Deal

    Iowa's attorney general Monday pressed the Fifth Circuit to reject investors' deal with The Charles Schwab Corp. in an antitrust suit over its merger with TD Ameritrade, arguing it offers only uncertain and hypothetical relief to class members while giving named plaintiffs and class counsel a "windfall."

  • March 24, 2026

    Conservative Group Bucks Trump, FCC On Nexstar Deal

    A major conservative group has come out swinging against the Federal Communications Commission's decision to waive the national TV broadcast ownership cap to let the merger of media giants Nexstar and Tegna move forward.

  • March 24, 2026

    6 Firms Guide Gilead's $2.2B Autoimmune Drug Play

    Gilead Sciences Inc. has agreed to acquire privately held Ouro Medicines for up to $2.175 billion and is in advanced discussions with Galapagos NV on a potential research and development collaboration on the assets, according to an announcement late Monday from Gilead.

Expert Analysis

  • Defeating Estoppel-Based Claims In Legal Malpractice Actions

    Author Photo

    State supreme court cases from recent years have addressed whether positions taken by attorneys in an underlying lawsuit can be used against them in a subsequent legal malpractice action, providing a foundation to defeat ex-clients’ estoppel claims, says Christopher Blazejewski at Sherin and Lodgen.

  • Series

    The Biz Court Digest: How It Works In Massachusetts

    Author Photo

    Since its founding in 2000, the Massachusetts Business Litigation Session's expertise, procedural flexibility and litigant-friendly case management practices have contributed to the development of a robust body of commercial jurisprudence, say James Donnelly at Mirick O’Connell, Felicia Ellsworth at WilmerHale and Lisa Wood at Foley Hoag.

  • Why Appellees Should Write Their Answering Brief First

    Author Photo

    Though counterintuitive, appellees should consider writing their answering briefs before they’ve ever seen their opponent’s opening brief, as this practice confers numerous benefits related to argument structure, time pressures and workflow, says Joshua Sohn at the U.S. Department of Justice.

  • FTC Focus: M&A Approvals A Year After Trump's Election

    Author Photo

    The Federal Trade Commission merger-enforcement regime a year since President Donald Trump's election shows how merger approvals have been expedited by the triaging out of more deals, grants for early termination of the Hart-Scott-Rodino waiting period, and zeroing in on preparing solutions for the biggest problems, say attorneys at Proskauer.

  • Series

    Mindfulness Meditation Makes Me A Better Lawyer

    Author Photo

    Mindful meditation enables me to drop the ego, and in helping me to keep sight of what’s important, permits me to learn from the other side and become a reliable counselor, says Roy Wyman at Bass Berry.

  • HSR Data Shows Most Deals Exit Antitrust Review Unscathed

    Author Photo

    Merger activity is up, enforcement is down and the vast majority of deals are emerging from U.S. federal antitrust review in one piece, new 2024 fiscal-year Hart-Scott-Rodino data shows, meaning companies should not shy away from deals based on a perception that recent antitrust enforcement has been unusually aggressive, says Amanda Wait at Michael Best.

  • AI Litigation Tools Can Enhance Case Assessment, Strategy

    Author Photo

    Civil litigators can use artificial intelligence tools to strengthen case assessment and aid in early strategy development, as long as they address the risks and ethical considerations that accompany these uses, say attorneys at Barnes & Thornburg.

  • Attys Beware: Generative AI Can Also Hallucinate Metadata

    Author Photo

    In addition to the well-known problem of AI-generated hallucinations in legal documents, AI tools can also hallucinate metadata — threatening the integrity of discovery, the reliability of evidence and the ability to definitively identify the provenance of electronic documents, say attorneys at Law & Forensics.

  • DOJ's UnitedHealth Settlement Highlights New Remedies Tack

    Author Photo

    The use of divestitures and Hart-Scott-Rodino Act compliance in the recent U.S. Department of Justice settlement with UnitedHealth Group and Amedisys underscores the DOJ Antitrust Division's willingness to utilize merger remedies under the second Trump administration, say attorneys at Buchanan Ingersoll.

  • When Atty Ethics Violations Give Rise To Causes Of Action

    Author Photo

    Though the Model Rules of Professional Conduct make clear that a violation of the rules does not automatically create a cause of action, attorneys should beware of a few scenarios in which they could face lawsuits for ethical lapses, says Brian Faughnan at Faughnan Law.

  • A Shift To Semiannual Reporting May Reshape Litigation Risk

    Author Photo

    While the U.S. Securities and Exchange Commission's proposed change from quarterly to semiannual reporting may reduce the volume of formal filings, it wouldn't reduce litigation risk, instead shifting it into less predictable terrain — where informal disclosures, timing ambiguities and broader materiality debates will dominate, says Pavithra Kumar at Advanced Analytical Consulting Group.

  • TikTok Divestiture Deal Revolves Around IP Considerations

    Author Photo

    The divestiture deal between the U.S. and China to resolve a security dispute over TikTok's U.S. operations is seen as a diplomatic breakthrough, but its success hinges on the treatment of intellectual property and may set a precedent in the global contest over digital sovereignty and IP control, say attorneys at Brownstein Hyatt.

  • CFIUS Trends May Shift Under 'America First' Policy

    Author Photo

    The arrival of the Committee on Foreign Investment in the United States' latest annual report suggests that the Trump administration's "America First" policy will have a measurable effect on foreign investment, including improved trendlines for investments from allied sources and increasingly negative trendlines for those from foreign adversary sources, say attorneys at Debevoise.

  • Lessons From Del. Chancery Court's New Activision Decision

    Author Photo

    The Delaware Court of Chancery's recent decision in AP-Fonden v. Activision Blizzard, declining to dismiss certain fiduciary duty claims at the pleading stage, offers takeaways for boards considering a sale, including the importance of playing an active role in the merger process and documenting key board materials, say attorneys at Cleary.

  • Series

    Practicing Stoicism Makes Me A Better Lawyer

    Author Photo

    Practicing Stoicism, by applying reason to ignore my emotions and govern my decisions, has enabled me to approach challenging situations in a structured way, ultimately providing advice singularly devoted to a client's interest, says John Baranello at Moses & Singer.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.